Understanding "Heparin Resistance" in Cardiac Surgery: Altered Heparin Responsiveness and Its Association With Acute Inflammatory Reactions.
Phase of Trial: Phase III
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Antithrombin alfa (Primary) ; Heparin
- Indications Blood coagulation disorders
- Focus Biomarker; Pharmacodynamics
- 07 Jan 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 28 Aug 2014 Planned number of patients changed from 2800 to 500 as reported by ClinicalTrials.gov record.
- 05 Jun 2012 Planned initiation date changed from 1 May 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.